Travaux scientifiques

Doç. Dr. Semiha Urvay

33 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. Evaluation of inflammatory parameters and ferritin as prognostic factors in non-small cell lung cancer patients receiving nivolumab immunotherapy

    Biomarkers, 2026

    DOI 10.1080/1354750x.2026.2621291 PMID 41579336 1 citation (Europe PMC) Source : OpenAlex

  2. Bone Metastasis Distribution Matters: Prognostic Effect of the Axial‐to‐Peripheral Ratio in Metastatic Hormone‐Sensitive Prostate Cancer

    The Prostate, 2026

    DOI 10.1002/pros.70176 PMID 41950364 Source : OpenAlex

  3. Does the Duration of FLOT Infusion Change the Outcome of Perioperative Treatment for Gastric Cancer? Comparing 24- and 48-h Infusions

    Medicina, 2026

    DOI 10.3390/medicina62050987 PMID 42195240 Texte intégral en libre accèsSource : OpenAlex

  4. Palliative Care Awareness Among Caregivers of Cancer Patients in Turkey: A Cross-Sectional Study

    Current Oncology, 2026

    DOI 10.3390/curroncol33080458 PMID 42645362 Texte intégral en libre accèsSource : OpenAlex

  5. Assessing Early Treatment Response in mCSPC using KELIM PSA Score: Implications for Survival

    Urologia Internationalis, 2026

    DOI 10.1159/uin/aewag017 PMID 42671968 Source : OpenAlex

  6. Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer

    Scientific Reports, 2025

    DOI 10.1038/s41598-025-96157-6 PMID 40188172 8 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  7. Prognostic value of IMDC score in non-small cell lung cancer receiving immunotherapy: old dog, new tricks?

    European Journal of Clinical Pharmacology, 2025

    DOI 10.1007/s00228-025-03810-0 PMID 39971806 1 citation (Europe PMC) Source : OpenAlex

  8. Prognostic Effect of KELIM Score of Prostate‐Specific Antigen in Hormone‐Sensitive Prostate Cancer Patients Treated With Novel Androgen Receptor Inhibitors: Pioneering New Ways

    The Prostate, 2025

    DOI 10.1002/pros.70098 PMID 41277135 Source : OpenAlex

  9. HEREDITARY COLORECTAL CANCER SYNDROMES

    Turkiye Klinikleri eBooks, 2025

    DOI 10.5336/978-625-395-770-4_p17 Source : OpenAlex

  10. A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy

    Medicine, 2024

    DOI 10.1097/md.0000000000037972 PMID 38787994 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  11. 1523P Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer

    Annals of Oncology, 2024

    DOI 10.1016/j.annonc.2024.08.1586 Source : OpenAlex

  12. Evaluating the effect of tumor size and sidedness on prognosis in stage 2 colon cancer: a retrospective population study.

    PubMed, 2022

    DOI 10.26355/eurrev_202202_28126 PMID 35253189 1 citation (Europe PMC) Source : OpenAlex

  13. Onkolojide Moleküler Hedefli Tedaviler

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1478 Texte intégral en libre accèsSource : OpenAlex

  14. Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience

    Cancer Investigation, 2021

    DOI 10.1080/07357907.2021.1933011 PMID 34014777 10 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  15. Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group

    Journal of Gastrointestinal Cancer, 2021

    DOI 10.1007/s12029-021-00594-1 PMID 33538958 4 citations (Europe PMC) Source : OpenAlex

  16. Prognostic role of pre-operative serum ferritin level in stage 2 colon cancer.

    PubMed, 2021

    DOI 10.26355/eurrev_202111_27091 PMID 34787851 12 citations (Europe PMC) Source : OpenAlex

  17. Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer

    Tumori Journal, 2020

    DOI 10.1177/0300891620969823 PMID 33167790 4 citations (Europe PMC) Source : OpenAlex

  18. Chemotherapy at the End of Life

    Journal of Palliative Care, 2020

    DOI 10.1177/0825859720946505 PMID 32762320 11 citations (Europe PMC) Source : OpenAlex

  19. The role of primary tumor resection in patients with stage IV colorectal cancer with unresectable metastases.

    PubMed, 2020

    PMID 32521889 7 citations (Europe PMC) Source : OpenAlex

  20. P1.01-45 Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey

    Journal of Thoracic Oncology, 2018

    DOI 10.1016/j.jtho.2018.08.601 Texte intégral en libre accèsSource : OpenAlex

  21. Crizotinib Efficacy in ALK-positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experince from Turkey

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Source : OpenAlex

  22. Crizotinib Efficacy in ALK-positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey

    Bursa Uludag University - AVESIS, 2018

    Source : OpenAlex

  23. CRIZOTINIB EFFICACY IN ALK-POSITIVE ADVANCEDSTAGE NON-SMALL CELL LUNG CANCER PATIENTS: A REAL-WORLD EXPERIENCE FROM TURKEY

    Kocaeli Üniversitesi - AVESİS, 2018

    Source : OpenAlex

  24. Perspective of Turkish Medicine Students on Cancer, Cancer Treatments, Palliative Care, and Oncologists (ARES Study): a Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)

    Journal of Cancer Education, 2018

    DOI 10.1007/s13187-018-1441-6 PMID 30446981 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  25. Comparison of survival with somatostatin analog and chemotherapy and prognostic factors for treatment in 165 advanced neuroendocrine tumor patients with Ki-67 20% or less

    Anti-Cancer Drugs, 2016

    DOI 10.1097/cad.0000000000000445 PMID 27768606 7 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  26. Mide Kanserinde Tanı Anındaki Evre ile Patolojik Alt Tip ve Lokalizasyonun İlişkisi

    2015

    Source : OpenAlex

  27. Meme Kanseri Hastalarında Tümör Belirteçleriyle Evre ve Prognostik Faktörler Arasındaki İlişki

    Trakya University's Institutional Open Access System (Trakya University), 2014

    Texte intégral en libre accèsSource : OpenAlex

  28. Gliomlara yaklaşım ve yeni tedaviler

    2013

    Source : OpenAlex

  29. Hastalarımızda tromboz sıklığı ve literatürün gözden geçirilmesi

    2012

    Source : OpenAlex

  30. Mide kanserinde helicobacter pylori infeksiyonu ile sağkalım arasındaki ilişki

    2011

    Source : OpenAlex

  31. Metastatik meme kanseri hastalarında, primer tümör ve metastazda hormon reseptör ve her-2 ekspresyon değişiklikleri

    Source : page de profil sur acibadem.com.tr

  32. Soluble endothelial cell protein C receptor and thrombomodulin levels after renal transplantation

    Source : page de profil sur acibadem.com.tr

  33. Bileteral total kalça protezi sonrası gelişen primer kemik lenfoması.

    Source : page de profil sur acibadem.com.tr